These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29889757)

  • 1. Maternal Complications Associated With Periviable Birth.
    Rossi RM; DeFranco EA
    Obstet Gynecol; 2018 Jul; 132(1):107-114. PubMed ID: 29889757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe adverse maternal outcomes associated with chorioamnionitis.
    Perry AK; Rossi RM; DeFranco EA
    Am J Obstet Gynecol MFM; 2019 Aug; 1(3):100027. PubMed ID: 33345791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary Trends in Cesarean Delivery Utilization for Live Births Between 22 0/7 and 23 6/7 Weeks of Gestation.
    Rossi RM; Hall E; DeFranco EA
    Obstet Gynecol; 2019 Mar; 133(3):451-458. PubMed ID: 30741810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between mode of delivery and infant survival at 22 and 23 weeks of gestation.
    Czarny HN; Forde B; DeFranco EA; Hall ES; Rossi RM
    Am J Obstet Gynecol MFM; 2021 Jul; 3(4):100340. PubMed ID: 33652159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Term Induction in Trial of Labor After Cesarean Delivery: Analysis of a Modern Obstetric Cohort.
    Lappen JR; Hackney DN; Bailit JL
    Obstet Gynecol; 2015 Jul; 126(1):115-23. PubMed ID: 26241264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal and Neonatal Morbidity Associated With Early Term Delivery of Large-for-Gestational-Age But Nonmacrosomic Neonates.
    Doty MS; Chen HY; Sibai BM; Chauhan SP
    Obstet Gynecol; 2019 Jun; 133(6):1160-1166. PubMed ID: 31135729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mode of Delivery in Previable Births.
    Rossi RM; DeFranco EA
    Am J Perinatol; 2019 Jan; 36(1):53-61. PubMed ID: 29883985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serious maternal complications after early preterm delivery (24-33 weeks' gestation).
    Reddy UM; Rice MM; Grobman WA; Bailit JL; Wapner RJ; Varner MW; Thorp JM; Leveno KJ; Caritis SN; Prasad M; Tita AT; Saade GR; Sorokin Y; Rouse DJ; Blackwell SC; Tolosa JE; ;
    Am J Obstet Gynecol; 2015 Oct; 213(4):538.e1-9. PubMed ID: 26164696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal outcomes associated with early preterm cesarean delivery.
    Kawakita T; Reddy UM; Grantz KL; Landy HJ; Desale S; Iqbal SN
    Am J Obstet Gynecol; 2017 Mar; 216(3):312.e1-312.e9. PubMed ID: 27840144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Cerclage with Composite Adverse Outcomes among Women Delivered at 36 Weeks or Later.
    Stephens AJ; Chen HY; Chauhan SP; Sibai B
    Am J Perinatol; 2020 Dec; 37(14):1400-1410. PubMed ID: 32521562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal morbidity after early preterm delivery (23-28 weeks).
    Romagano MP; Fofah O; Apuzzio JJ; Williams SF; Gittens-Williams L
    Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100125. PubMed ID: 33345871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between route of delivery and maternal adverse outcomes in pregnancies complicated by preterm birth.
    Wiley R; Chen HY; Wagner SM; Gupta M; Chauhan SP
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9694-9701. PubMed ID: 35272552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between gestational age and maternal adverse outcomes in patients undergoing trial of labor after cesarean.
    Rasiah SS; Young A; Raker C; Lewkowitz AK; Gupta M; Bartal MF; Wagner SM
    Minerva Obstet Gynecol; 2024 Aug; 76(4):312-318. PubMed ID: 36345903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal and neonatal adverse outcomes in individuals with a prior cesarean birth who undergo induction at 39 weeks.
    Uwanaka O; Raker C; Gupta M; Bicocca MJ; Fishel Bartal M; Chauhan SP; Wagner S
    Eur J Obstet Gynecol Reprod Biol; 2022 Jan; 268():12-17. PubMed ID: 34788720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal and Neonatal Outcomes in Indicated Preterm Births Based on the Intended Mode of Delivery.
    Kuper SG; Sievert RA; Steele R; Biggio JR; Tita AT; Harper LM
    Obstet Gynecol; 2017 Nov; 130(5):1143-1151. PubMed ID: 29016494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reported Prevalence of Maternal Hepatitis C Virus Infection in the United States.
    Rossi RM; Wolfe C; Brokamp R; McAllister JM; Wexelblatt S; Warshak CR; Hall ES
    Obstet Gynecol; 2020 Feb; 135(2):387-395. PubMed ID: 31923064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal and Maternal Adverse Outcomes Among Low-Risk Parous Women at 39-41 Weeks of Gestation.
    Chen HY; Grobman WA; Blackwell SC; Chauhan SP
    Obstet Gynecol; 2019 Aug; 134(2):288-294. PubMed ID: 31306312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe maternal morbidity associated with cerclage use in pregnancy.
    Lee M; Rossi RM; DeFranco EA
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5957-5963. PubMed ID: 33771076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of chorioamnionitis and its duration with adverse maternal outcomes by mode of delivery: a cohort study.
    Venkatesh KK; Glover AV; Vladutiu CJ; Stamilio DM
    BJOG; 2019 May; 126(6):719-727. PubMed ID: 30485648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidity.
    Metz TD; Allshouse AA; Hogue CJ; Goldenberg RL; Dudley DJ; Varner MW; Conway DL; Saade GR; Silver RM
    Am J Obstet Gynecol; 2017 Oct; 217(4):478.e1-478.e8. PubMed ID: 28578174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.